The ATS 2025 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in sleep medicine, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 16–21 in San Francisco, visit the online Advance Program.
- A109 SMOKE, SNOOZE, AND ICU BLUES: THE INFLUENCE OF ENVIRONMENTAL EXPOSURES AND CRITICAL CARE CONDITIONS ON SLEEP
- A18 BEST TRIALS IN PULMONARY REHABILITATION
- A30 BIOMARKERS, PREDICTORS, AND MODIFIERS OF PEDIATRIC PULMONARY OUTCOMES
- A64 EVALUATION AND TESTING FOR PEDIATRIC LUNG DISEASES
- A7 INCLUDE: ADVANCES IN PEDIATRIC OSA THROUGH DOWN SYNDROME-FOCUSED TRIALS
- A75 RUNNING DIAGNOSTICS: WHAT’S NEW IN LUNG PHYSIOLOGY?
- B105 PULMONARY FUNCTION TESTING, IMAGING, AND DIAGNOSTIC TOOLS FOR PEDIATRIC PULMONARY DISEASES
- B31 DISPARITIES IN SLEEP: DIFFERENCES IN OSA DX, CPAP USE, DAYTIME FUNCTION, AND SOCIAL DETERMINANTS OF HEALTH
- B79 SLEEP BY THE NUMBERS: TRACKING RISKS, OUTCOMES, AND REAL-WORLD IMPACT
- B89 THERAPEUTIC INNOVATIONS FOR WEIGHT MANAGEMENT IN OSA: FROM METABOLIC MODULATION TO WEIGHT LOSS
- B9 CONTEMPORARY DISEASE-MODIFYING THERAPIES: UPDATES FOR THE PEDIATRIC PULMONOLOGIST
- B95 OMICS CONTINUE TO IDENTIFY MECHANISMS UNDERLYING CHILDHOOD LUNG DISEASES
- C20 CROSSING THE GOLDEN GATE: INNOVATIVE OSA TREATMENT TRIALS AND CARDIOVASCULAR OUTCOMES
- C22 BIG DATA AND TECHNOLOGY IN RESPIRATORY MEDICINE
- C27 GENETICS AND -OMICS TO PREDICT AND UNDERSTAND CHILDHOOD LUNG DISEASES
- C30 HYPOXIC HORIZONS: UNRAVELING EPIGENETICS, CARDIOMETABOLIC FINDINGS AND MICROPLASTICS IN MURINE MODELS
- C87 SLEEP AND SUDDEN DEATH
- CC6 ADULT SLEEP CLINICAL CORE CURRICULUM
- D19 IN THE SHALLOW: EXPLORING SLEEP RELATED HYPOVENTILATION DISORDERS
- D27 CELLULAR MECHANISMS AND IMMUNE PATHWAYS UNDERLYING PEDIATRIC PULMONARY DISEASES
- D3 CHICKEN OR EGG: DISENTANGLING THE ROLE OF COMORBIDITIES IN FIBROTIC INTERSTITIAL LUNG DISEASES
- D30 GOING WITH THE FLOW: ABNORMALITIES IN RESPIRATORY MECHANICS
- D7 TECHNOLOGICAL ADVANCEMENTS IN PEDIATRIC PULMONOLOGY: REMOTE DATA AND DECISION SUPPORT
- D84 STRATEGIES TO IMPROVE PATIENT-CENTEREDNESS AND DIVERSITY IN CLINICAL TRIALS OF OSA CARE
- D94 INROADS INTO NOVEL THERAPEUTICS AND DELIVERY APPROACHES FOR PEDIATRIC LUNG DISEASES
- NCE23 Strategies to Reduce Pulmonary and Critical Care Practice Emissions
- PG20 TACKLING OBESITY IN PATIENTS WITH SLEEP-DISORDERED BREATHING
- PG3 ADVANCES IN THE MANAGEMENT OF COMPLEX SLEEP-DISORDERED BREATHING AND CHRONIC RESPIRATORY FAILURE
Register Today for ATS 2025
Register today for the ATS 2025 International Conference! Don’t miss the opportunity to experience this year’s premier respiratory health conference, May 16-21 in San Francisco. Join your colleagues to learn about the latest pulmonary, critical care, and sleep medicine developments. Not an ATS member? Join today and save on your conference registration!